Researchnester

       The global Cognitive Neuroscience Market was valued at USD 41.2 billion in 2025 and is projected to surpass USD 77 billion by 2035 , growing at a compound annual growth rate (CAGR) of more than 7.2% between 2026 and 2035. This robust expansion reflects increasing investment in brain research, the integration of advanced technologies such as AI in cognitive analysis, and rising demand for non-invasive neurological diagnostic tools across healthcare and academic institutions. Cognitive Neuroscience Industry Demand The Cognitive Neuroscience Market revolves around the scientific and technological study of the brain’s cognitive functions using advanced imaging, analytical software, and neuroinformatics platforms. It encompasses hardware such as EEG, fMRI, PET, and NIRS, as well as software and AI-driven analytics designed to decode neural activity patterns. Demand for cognitive neuroscience tools is rising due to their cost-effectiveness , ease of admin...

  The Mental Health Apps Market has emerged as one of the fastest-growing digital healthcare segments, driven by rising awareness of mental well-being and the increasing adoption of smartphones worldwide. The market was estimated at USD 7.5 billion in 2025 and is anticipated to rise to USD 35.2 billion by 2035 , growing at a CAGR of 15.1% over the forecast period from 2026 to 2035. This growth trajectory is largely fueled by the growing prevalence of mental health disorders, the shift toward digital therapeutic solutions, and the affordability of app-based mental health interventions compared to traditional in-person therapy sessions. Mental Health Apps Industry Demand The Mental Health Apps Market encompasses a wide range of digital platforms designed to support users in managing psychological conditions, promoting emotional well-being, and enhancing overall mental resilience. These apps provide solutions for depression, anxiety, stress, meditation, sleep improvement, and...

  The global Transparent Aluminum Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.7 billion by the end of 2034 , growing at a CAGR of 8.3% during the forecast period (2025–2034). The increasing deployment of advanced materials in defense, aerospace, and electronics industries has propelled demand for high-performance, transparent, and durable alternatives to traditional glass and plastics, positioning transparent aluminum as a key material for future applications. Transparent Aluminum Industry Demand Transparent aluminum refers to a class of advanced ceramic materials, primarily including aluminum oxynitride (ALON) and aluminum nitride, known for their exceptional strength, optical clarity, and thermal stability. It combines the optical transparency of glass with the hardness of sapphire, making it ideal for high-stress, high-precision applications. The demand for transparent aluminum is driven by: ·       ...

  The global Manganese Alloy Market is expected to increase at a compound annual growth rate (CAGR) of 6% from 2025 to 2034, from its 2024 valuation of USD 28.5 billion to USD 53.5 billion. This growth reflects the expanding role of manganese alloys in critical end-use industries such as steel manufacturing, superalloys, and advanced foundry materials, driven by increasing industrialization and infrastructure development globally. Manganese Alloy Industry Demand Manganese alloys are key components in metallurgy, particularly in steelmaking, where they serve as essential deoxidizers and desulfurizing agents. They include various blends such as silicomanganese and ferromanganese, each with specific properties tailored to particular industrial uses. The demand for manganese alloy products is being propelled by their cost-effectiveness , long shelf life , and ease of use in large-scale industrial processes . These alloys contribute to enhanced tensile strength , hardness , and...

  The Multiple Sclerosis Drug Market is expected to increase at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2034, from its 2024 valuation of USD 27.8 billion to USD 48.5 billion by the end of 2034. This steady growth reflects continued investment in research, the rising prevalence of MS worldwide, and an expanding treatment portfolio ranging from disease-modifying therapies (DMTs) to next-generation biologics. Multiple Sclerosis Drug Industry Demand The Multiple Sclerosis (MS) Drug Market encompasses a wide range of pharmaceutical treatments aimed at managing the symptoms and progression of MS—an autoimmune disorder that disrupts communication between the brain and the rest of the body. The medications are intended to either control flare-ups, reduce symptoms, or limit the progression of the disease. Several factors are contributing to the growing demand for MS drugs: ·          Cost-effectiveness : With ongoing innov...